In serum of 57 patients, we found that IL-4, IL-6, IFN-γ, and TNF-α significantly increased in multiple myeloma compared with healthy control, especially IL-6 and IFN-γ (Table 6). This evidence concerns the gene IFNG and plasma cell myeloma.